Follow the Krsnaa Diagnostics Limited stock price and the full management transaction log of the company, a publicly traded company based in India. Shares are quoted on the IN market, under the supervision of SEBI (PIT + SAST). Operating in the Health Care sector, Krsnaa Diagnostics Limited has published 13 reports. Market capitalisation: €17.1bn. The latest transaction was filed on 30 December 2024 (Purchase). Among the most active insiders: Phi Capital Trust - Phi Capital Growth Fund - 1. Every trade is accessible without an account.
13
Insider Decl.
n/a
Thresholds
€3m
13 ops.
Buy Volume
n/a
n/a
Sell Volume
10Σ signal
Buys €3mn/a Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 8,910 of 29,064 companies
61.2
score / 100
Value
54
Quality
69
FCF yld-4.5%
Earn yld5.9%
EV/EBITDA8.8x
ROE11%
Gross mgn69%
Net mgn13%
Debt/EBITDA2.1x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.